The purpose of the proposed program is to provide research training in oncology to young surgeons interested in academic surgical oncology as their primary focus. Trainees will be surgical residents with 2 or more years of postgraduate clinical experience. This Surgical Oncology Research Training Program has supported the research careers of 40 young trainee surgeons over the past 20 years. We are now applying for funding of years 21-26.. The goals of the two-year training program are to provide individuals with an intensive research experience in (1) hypothesis formulation and hypothesis testing, (2) experimental design, (3) data analysis, and (4) oral and written presentation. The ultimate objective of the program is to provide individuals with the scientific background and experience necessary to plan and perform high quality independent research in oncology upon completion of their surgical training. This research experience will enable trainees to apply for positions as junior faculty members in academic institutions and become independent and mentored clinical investigators and translational researchers. The program will vary according to the interest of the trainees and their preceptors;however, the program curriculum is designed to provide exposure to medical oncology, radiation oncology, clinical surgical oncology as well as basic science. Past trainees have worked in a wide variety of disciplines, including tumor immunology, cancer cell biology, immunobiology, immunophysiology, molecular genetics, angiogenesis, biochemistry, nutrition, pharmacology, molecular pathology, targeted therapeutics, therapeutic cloning, and growth and differentiation. Close contact between the trainee, preceptor and program director has been achieved. Trainees are required to attend weekly conferences and didactic lectures at Memorial Sloan-Kettering Cancer Center (MSKCC) to include clinical and laboratory seminars, case studies, tumor rounds, lectures on hypothesis formulation and testing as well as research design. The scientific quality of research performed by the trainees has been outstanding, and most of the fellows in the past 10 years have remained in academia. Given the success of the present program, expanding research resources and facilities at our institution, and the increased number of experienced mentors we request to expand the number of research training positions from 2 to 4 trainees per year.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009501-25
Application #
8091446
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
1984-09-01
Project End
2012-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
25
Fiscal Year
2011
Total Cost
$224,567
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Zhang, Jennifer Q; Zeng, Shan; Vitiello, Gerardo A et al. (2018) Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors. Cancer Immunol Res 6:434-447
Brandt, Whitney S; Bouabdallah, Ilies; Tan, Kay See et al. (2018) Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma. J Thorac Cardiovasc Surg 155:1212-1224.e3
Brandt, Whitney S; Yan, Wanpu; Leeman, Jonathan E et al. (2018) Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer. Ann Thorac Surg 106:848-855
Vitiello, Gerardo A; Medina, Benjamin D; Zeng, Shan et al. (2018) Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor. Clin Cancer Res 24:972-984
Lee, Jun H; Chang, Kevin K; Yoon, Changhwan et al. (2018) Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma. Ann Surg 267:105-113
García Nores, Gabriela D; Ly, Catherine L; Savetsky, Ira L et al. (2018) Regulatory T Cells Mediate Local Immunosuppression in Lymphedema. J Invest Dermatol 138:325-335
Ly, Catherine L; Cuzzone, Daniel A; Kataru, Raghu P et al. (2018) Small numbers of CD4+ T cells can induce development of lymphedema. Plast Reconstr Surg :
García Nores, Gabriela D; Ly, Catherine L; Cuzzone, Daniel A et al. (2018) CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun 9:1970
Brandt, Whitney S; Yan, Wanpu; Zhou, Jian et al. (2018) Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis. J Thorac Cardiovasc Surg :
Ho, Alice Y; Hu, Zishuo I; Mehrara, Babak J et al. (2017) Radiotherapy in the setting of breast reconstruction: types, techniques, and timing. Lancet Oncol 18:e742-e753

Showing the most recent 10 out of 166 publications